Medical Director(Hematology/Oncology) - Remote U.S
Thermo Fisher Scientific- Full Time
- Senior (5 to 8 years)
Candidates should possess a Bachelor’s degree in Medical Writing, Scientific Writing, Biology, or a related scientific field, and have at least 8 years of experience in medical writing, with a minimum of 5 years in the pharmaceutical or biotechnology industry. Strong knowledge of regulatory requirements for drug development, including FDA guidelines and ICH guidelines, is essential. Demonstrated experience in authoring and reviewing complex regulatory documents, such as clinical study reports, investigator’s brochures, and regulatory submissions, is required. Excellent writing, editing, and communication skills are necessary, along with the ability to work independently and as part of a team.
The Senior Manager, Medical Writing will author a wide variety of documents of all types and complexities, such as clinical study reports (CSRs all phases), investigator’s brochures, CTD summaries/overviews, PIPs/PIP modifications, and regulatory responses. They will represent Medical Writing in cross-functional teams, such as product, project and/or regulatory submissions teams; providing guidance for optimal presentation of data to achieve document intent. They will plan and oversee assigned medical writing deliverables, including development and management of document timelines and resource planning for assigned projects. They may serve as the filing lead for small to medium regulatory submissions and may serve as lead medical writer and department representative across development programs. The role involves participating in the development/improvement of document standards, templates, and processes, and may also involve coaching, training, and providing guidance to less experienced Medical Writing colleagues. They will manage or supervise contractors to ensure the highest quality of medical writing and adherence to Gilead documents standards.
Develops and commercializes biopharmaceuticals
Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.